iBio (IBIO) Shares Outstanding (Entity) (2010 - 2026)
iBio's Shares Outstanding (Entity) was 104.06 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 891.1% from 10.5 million a year earlier but down 13.0% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
From fiscal Q1 2011 onward, iBio has reported Shares Outstanding (Entity) for 64 quarters.
- Shares Outstanding (Entity) has now increased for four consecutive fiscal years, with a five-year compound annual growth rate of 57.0% (FY2021 to FY2026).
- In earlier fiscal years, Shares Outstanding (Entity) was 10.5 million in FY2025 (+174.1%), 3.83 million in FY2024 (+525.7%), 612,250 in FY2023 (+40.3%) and 436,358 in FY2022 (-96.0%).
- Quarterly Shares Outstanding (Entity) has moved between 436,358 (fiscal Q4 2022) and 119.6 million (fiscal Q3 2026) over five years.
- The best year-over-year quarter for Shares Outstanding (Entity) over five years was fiscal Q2 2026 (growth of 981.3%); the worst was fiscal Q4 2022 (a decline of 96.0%).
- Per Business Quant data, IBIO's Shares Outstanding (Entity) in the three fiscal quarters before Q4 2026 was 119.6 million (Q3 2026), 99.13 million (Q2 2026) and 52.98 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | iBio | 122.79 Mn | 122.79 Mn | - | 104.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 104.06 Mn |
| Mar 31, 2026 | 119.60 Mn |
| Dec 31, 2025 | 99.13 Mn |
| Sep 30, 2025 | 52.98 Mn |
| Jun 30, 2025 | 10.50 Mn |
| Mar 31, 2025 | 10.07 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Sep 30, 2024 | 8.64 Mn |
| Jun 30, 2024 | 3.83 Mn |
| Mar 31, 2024 | 3.71 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 1.38 Mn |
| Jun 30, 2023 | 612,250.00 |
| Mar 31, 2023 | 618,414.00 |
| Dec 31, 2022 | 490,350.00 |
| Sep 30, 2022 | 450,329.00 |
| Jun 30, 2022 | 436,358.00 |
| Mar 31, 2022 | 10.91 Mn |
| Dec 31, 2021 | 10.90 Mn |
| Sep 30, 2021 | 10.90 Mn |
API Access
iBio Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();